|Page (1) of 1 - 02/14/18||email article||print page|
(February 14, 2018)
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the company’s management will participate in two upcoming investor conferences.
Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in the fifth annual BTIG Healthcare Conference, focused on medical technology, life sciences, and diagnostic tools, in Snowbird, Utah, on Wednesday, February 28, and Thursday, March 1.
Linthwaite and Jog will also participate in the Cowen and Company 38th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, Massachusetts. Linthwaite will present on Tuesday, March 13, 2018, at 9:20 am ET, with a breakout to follow at 10:00 am ET.
A live webcast of the company’s presentation and subsequent replay may be accessed at http://investors.fluidigm.com/events.cfm. The webcast will be archived for 90 days following the live presentation.
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
Fluidigm and the Fluidigm logo are trademarks and/or registered trademarks of Fluidigm Corporation.
Ana PetrovicDirector, Corporate Development and Investor Relations
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter